Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/06/2014EP2760852A1 Improved process for the preparation of sulfamide derivatives
08/06/2014EP2760851A1 Process for the preparation of sulfamide derivatives
08/06/2014EP2760848A1 Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation
08/06/2014EP2760843A2 Selective nr2b antagonists
08/06/2014EP2760842A1 An improved process for the preparation of bendamustine hydrochloride
08/06/2014EP2760841A1 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
08/06/2014EP2760840A1 Quinolinone carboxamide inhibitors of endothelial lipase
08/06/2014EP2760839A1 Pyridinedione carboxamide inhibitors of endothelial lipase
08/06/2014EP2760838A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
08/06/2014EP2760837A1 Substituted methanesulfonamide derivatives as vanilloid receptor ligands
08/06/2014EP2760836A1 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands
08/06/2014EP2760835A1 Aryl or n-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands
08/06/2014EP2760834A1 Pyridinedione carboxamide inhibitors of endothelial lipase
08/06/2014EP2760833A1 Pyridine derivatives
08/06/2014EP2760830A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014EP2760829A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014EP2760828A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/06/2014EP2760827A2 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
08/06/2014EP2760826A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
08/06/2014EP2760823A1 Novel compounds as hif-1alpha inhibitors and manufacturing process thereof
08/06/2014EP2760822A1 Desfesoterodine salts
08/06/2014EP2760821A1 Choline salt of an anti - inflammatory substituted cyclobutenedione compound
08/06/2014EP2760820A2 Sphingosine analogs, compositions, and methods related thereto
08/06/2014EP2760547A1 Antioxidant compositions for treatment of inflammation or oxidative damage
08/06/2014EP2760462A2 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions
08/06/2014EP2760461A1 Alisporivr for treatment of hepatis c virus infection
08/06/2014EP2760458A1 Prevention and/or treatment of cancer and/or cancer metastasis
08/06/2014EP2760457A1 Methods and pharmaceutical compositions for treating cancer
08/06/2014EP2760456A1 Combination therapy for chemoresistant cancers
08/06/2014EP2760455A1 Hydrogen sulfide releasing compounds and their use
08/06/2014EP2760454A1 Products for healing of tissue wounds
08/06/2014EP2760453A1 Macrocyclic lrrk2 kinase inhibitors
08/06/2014EP2760452A2 Methods of treating cancer
08/06/2014EP2760451A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
08/06/2014EP2760450A1 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders
08/06/2014EP2760449A1 A pharmaceutical composition for the treatment of stem cells
08/06/2014EP2760448A1 Pharmaceutical composition for the prevention and/or treatment of muscle atrophy
08/06/2014EP2760447A1 Antiviral therapies with phospholipase d inhibitors
08/06/2014EP2760446A1 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer)
08/06/2014EP2760445A1 Method of treating mucoepidermoid carcinoma
08/06/2014EP2760444A1 Cannabinoid carboxylic acids, salts of cannabinoid carboxylic acids, and the production and uses of same
08/06/2014EP2760443A1 Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor
08/06/2014EP2760442A1 Compositions containing spermine together with cadaverine, putrescine and/or spermidine
08/06/2014EP2760441A2 Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactives
08/06/2014EP2760440A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
08/06/2014EP2760439A2 Camphene reduces plasma cholesterol and triglycerides
08/06/2014EP2760434A1 Pharmaceutical compositions of n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide
08/06/2014EP2760283A1 High quality antimicrobial paint composition
08/06/2014CN103975057A 通过施用海藻糖提高作物产量的方法 Increase crop yields by applying the method of trehalose
08/06/2014CN103974965A 唾液酸类似物 Sialic acid analogs
08/06/2014CN103974964A β-C-芳基葡糖苷的制备方法 β-C- aryl glucoside preparation
08/06/2014CN103974957A 具有整合酶抑制活性的多环吡啶酮衍生物 Having an integrase inhibitory activity of polycyclic pyridine derivatives
08/06/2014CN103974956A 作为hdac6抑制剂和用作抗肿瘤剂的杂环酰胺化合物 As hdac6 inhibitor and as an anti-tumor agent heterocyclic amide compound
08/06/2014CN103974955A 嘧啶并-哒嗪酮化合物及其用途 Pyrimido - pyridazinone compound and use thereof
08/06/2014CN103974954A 调节激酶的化合物、含有它们的组合物及其用途 Compounds that modulate kinases, compositions containing them and their use
08/06/2014CN103974953A 激酶抑制剂 Kinase inhibitors
08/06/2014CN103974951A 6-二氟甲基-5,6-二氢-2h-[1,4]噁嗪-3-胺衍生物 6-fluoro-5,6-dihydro -2h- [1,4] oxazin-3-amine derivative
08/06/2014CN103974950A 作为ccr(4)拮抗剂的取代的苯并咪唑类和苯并吡唑类 As ccr (4) antagonists substituted benzimidazoles and benzo pyrazoles
08/06/2014CN103974948A 在治疗过度增殖性疾病中用作bub1激酶抑制剂的取代的苄基吲唑 Substituted bub1 kinase inhibitors used in the treatment of hyperproliferative diseases benzyl indazole
08/06/2014CN103974947A 可用于体内成像的5ht1a拮抗剂 Can be used for in vivo imaging 5ht1a antagonist
08/06/2014CN103974945A 用于制备神经氨酸衍生物的方法 Preparation process for derivatives of neuraminic acid
08/06/2014CN103974944A 用作kv3抑制剂的乙内酰脲衍生物 The inhibitor used kv3 hydantoin derivative
08/06/2014CN103974940A 5-(3-氨基苯基)-5-烷基-5,6-二氢-2h-[1,4]噁嗪-3-胺衍生物 5- (3-aminophenyl) -5-alkyl-5,6-dihydro--2h- [1,4] oxazin-3-amine derivative
08/06/2014CN103974938A 作为因子xia抑制剂的经取代的四氢异喹啉化合物 As inhibitors of factor xia substituted tetrahydroisoquinoline compound
08/06/2014CN103974934A 使用sirt2调节剂的治疗方法 Methods of treatment using sirt2 modulators
08/06/2014CN103974707A 治疗性硫酸化多糖、其组合物及治疗患者的方法 Therapeutic sulfated polysaccharide, which composition and method for treating a patient
08/06/2014CN103974706A 嗜酸细胞性食管炎的治疗 Eosinophilic esophagitis treatment
08/06/2014CN103974705A 用于炎症性疾病、过敏性疾病和自身免疫性疾病的药物组合物 A pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
08/06/2014CN103974704A 以拉喹莫德和芬戈莫德的组合治疗多发性硬化症 Combination with laquinimod and fingolimod treatment of multiple sclerosis
08/06/2014CN103974703A 卡巴他赛制剂及其制备方法 Cabazitaxel and its preparation method
08/06/2014CN103974702A 癌性贫血改善/预防剂 Improve cancer-related anemia / preventive agent
08/06/2014CN103974701A 慢性肾脏病的改善、预防剂 Chronic kidney disease, prevention agent
08/06/2014CN103974700A 贴附剂 Adhesive patch
08/06/2014CN103974699A 咳嗽和咳嗽发作的治疗 Coughing and coughing attack treatment
08/06/2014CN103974698A 用于治疗缺血性损伤的半胱胺和/或胱胺 Cysteamine for the treatment of ischemic injury and / or cysteamine
08/06/2014CN103974696A 抗血小板剂、ω-3脂肪酸和直链淀粉的软明胶胶囊的稳定制剂 Antiplatelet agents, ω-3 fatty acids and amylose stable formulations of soft gelatin capsules
08/06/2014CN103974695A 苦味被遮蔽的枸橼酸西地那非口服薄膜制剂 Sildenafil citrate oral film formulation bitterness obscured
08/06/2014CN103974694A 用于治疗干眼病的组合物 For the treatment of dry eye compositions
08/06/2014CN103974631A 在固定诱导的肌肉萎缩后加速肌肉恢复 After a fixed-induced muscle atrophy accelerated muscle recovery
08/06/2014CN103974630A 增加羟基肉桂酸类的生物利用度 Increase the bioavailability of hydroxy cinnamic acids
08/06/2014CN103974619A 治疗法布里病的给药方案 Treatment of Fabry disease dosing regimen
08/06/2014CN103974617A 百里酚和桃拓酚抗菌组合物 Thymol and Totarol antimicrobial compositions
08/06/2014CN103965469A 液态外源性no供体及其制备和应用方法 No exogenous donor liquid and its preparation and application methods
08/06/2014CN103965458A 聚乙二醇-氨基酸寡肽-达沙替尼结合物及其药物组合物 Polyethylene Glycol - amino acid oligopeptide - dasatinib conjugates and pharmaceutical compositions thereof
08/06/2014CN103965421A 一种具有核壳结构的温敏性两亲嵌段共聚物的制备方法及其产品 Temperature-sensitive nature of a core-shell structure and product preparation of amphiphilic block copolymers
08/06/2014CN103965420A 一种基于二硫键还原响应型可降解药物载体及其制备和应用 Based on the reduction of disulfide bonds responsive biodegradable drug carrier and its preparation and application
08/06/2014CN103965398A D-半乳糖/苯甲醛氮芥/n-(2-羟丙基)甲基丙烯酰胺共聚物及其制备和应用 D- galactose / benzaldehyde mustard / n- (2- hydroxypropyl) methacrylamide copolymer and its preparation and application
08/06/2014CN103965367A 六月青多糖的制备及其抗乙肝病毒的作用 Liuyueqing polysaccharide preparation and the role of anti-hepatitis B virus
08/06/2014CN103965281A 一种原人参二醇衍生物、其制备方法及其应用 One kind protopanaxadiol derivatives, their preparation and their use
08/06/2014CN103965279A 一种新人参皂苷酸降解化合物、其制备方法及其医药用途 A new ginsenosides acid degradation compounds, their preparation and their medicinal uses
08/06/2014CN103965274A 一种芹菜素-7-o-β-D-葡萄糖醛酸苷制备方法及用途 One kind of apigenin -7-o-β-D- glucuronide preparation method and application
08/06/2014CN103965273A 一种大环内酯类化合物 A macrolide compound
08/06/2014CN103965215A 一种头孢唑林钠化合物及其无菌粉针 One kind of cefazolin sodium compounds and sterile powder for injection
08/06/2014CN103965214A 一种β-内酰胺类化合物及其制备方法和应用 One kind of β- lactam compound and preparation method and application
08/06/2014CN103965213A 7,8-二氢-6H-[1,4]噁嗪[3,2-g]喹唑啉类衍生物及其制备方法和用途 7,8-dihydro -6H- [1,4] oxazine [3,2-g] quinazoline derivatives and their preparation and use
08/06/2014CN103965212A 6,7,8,9-四氢-[1,4]氧氮杂卓[3,2-g]喹唑啉类衍生物及其制备方法和用途 6,7,8,9-tetrahydro - [1,4] oxazepine [3,2-g] quinazoline derivatives and their preparation and use
08/06/2014CN103965211A 含喹唑啉结构的三环类衍生物及其制备方法和用途 Quinazoline structure containing tricyclic derivatives and their preparation and use
08/06/2014CN103965208A 亲脂性的醇或酚修饰的脂溶性喜树碱类抗癌药物化合物和制剂、该化合物的制备方法及应用 Lipophilic alcohol or phenol-modified lipid soluble camptothecin class of anticancer compounds and pharmaceutical formulations, method of preparation and application of the compound
08/06/2014CN103965207A 一种新型四氢吡喃并[3,4-b]吲哚衍生物的制备及其抗肿瘤药物中的应用 A novel tetrahydropyrano [3,4-b] indole Preparation and antineoplastic derivatives Application
08/06/2014CN103965204A 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 Indazolo [5,4-a] pyrrolo [3,4-c] carbazole compounds of the new forms of